Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	66.82	127.97	163.03	180	116.05	65.13
Short-Term Investments	-	-	18.31	110.7	137.57	29.69
Cash & Short-Term Investments	66.82	127.97	181.34	290.71	253.62	94.82
Cash Growth	-60.67%	-29.43%	-37.62%	14.62%	167.48%	10.48%
Accounts Receivable	-	-	-	-	9.39	1.79
Other Receivables	-	8.67	-	-	-	-
Receivables	-	8.67	-	-	9.39	1.79
Inventory	-	29.65	-	-	-	-
Prepaid Expenses	6.1	9.12	13.42	12.92	5.77	3.59
Total Current Assets	72.93	175.41	194.76	303.63	268.78	100.19
Property, Plant & Equipment	95.48	132.25	133.97	36.15	22.94	30.85
Long-Term Investments	-	-	-	0.5	49.83	-
Other Long-Term Assets	10.34	50.94	20.05	14.59	1.4	1.4
Total Assets	178.74	358.6	348.78	354.86	342.94	132.44
Accounts Payable	8.25	3.64	17.44	13.74	4.02	4.86
Accrued Expenses	17.72	52.56	25.07	24	14.23	10.88
Current Portion of Long-Term Debt	-	-	0.46	-	0.45	-
Current Portion of Leases	8.35	6.68	3.6	6.61	5.12	4.46
Current Unearned Revenue	-	7.73	4.26	16.82	22.6	25.79
Other Current Liabilities	30.52	28.05	34.77	21.1	-	-
Total Current Liabilities	64.83	98.66	85.6	82.26	46.42	45.99
Long-Term Debt	-	101.54	50.59	24.64	24.64	24.65
Long-Term Leases	85.27	105.72	107.94	17.96	10.56	15.68
Long-Term Unearned Revenue	-	95.36	92.43	87	85.57	93.95
Other Long-Term Liabilities	4.72	2.17	1.44	11.5	1	0.5
Total Liabilities	154.82	403.46	338	223.35	168.19	180.76
Common Stock	0.17	0.14	0.13	0.09	0.09	0.07
Additional Paid-In Capital	986.21	933.24	875.18	745.83	723.48	411.26
Retained Earnings	-962.46	-978.24	-864.51	-614.35	-548.78	-459.65
Comprehensive Income & Other	-	-	-0.01	-0.06	-0.05	-
Total Common Equity	23.92	-44.86	10.78	131.51	174.75	-48.32
Shareholders' Equity	23.92	-44.86	10.78	131.51	174.75	-48.32
Total Liabilities & Equity	178.74	358.6	348.78	354.86	342.94	132.44
Total Debt	93.61	213.94	162.59	49.21	40.77	44.78
Net Cash (Debt)	-26.79	-85.97	18.75	241.5	212.85	50.04
Net Cash Growth	-	-	-92.24%	13.46%	325.39%	-41.70%
Net Cash Per Share	-0.18	-0.67	0.17	2.63	2.67	0.88
Filing Date Shares Outstanding	135.04	151.01	126.08	92.01	91.55	71.07
Total Common Shares Outstanding	135.04	135.04	125.22	91.89	91.46	70.14
Working Capital	8.1	76.75	109.17	221.37	222.36	54.2
Book Value Per Share	0.18	-0.33	0.09	1.43	1.91	-0.69
Tangible Book Value	23.92	-44.86	10.78	131.51	174.75	-48.32
Tangible Book Value Per Share	0.18	-0.33	0.09	1.43	1.91	-0.69
Machinery	-	38.65	31.58	23.61	19.89	19.05
Construction In Progress	-	1.39	3.97	1.67	0.35	0.21
Leasehold Improvements	-	33.55	32.47	32.93	27.98	27.98

Source: S&P Capital IQ. Standard template. Financial Sources.